Careers Contact Locations

OPKO Health, Inc.

  • Home
  • Who We Are
    • Our Vision
    • Our History
    • Our Leadership
  • What We Do
    • Overview
    • Our Products
    • Our Solutions
    • Our Technology
    • Our Research
    • Our Diagnostics
  • News & Media
    • Press Releases
    • Announcements
    • Events
    • Presentations
  • Investors
    • Overview
    • News / Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact
  • Locations

OPKO Acquires ModeX Therapeutics

Learn More

Press Releases

News & Media

News & Media

  • Press Releases
  • Announcements
  • Events
  • Presentations

Sema4 to Acquire GeneDx, Strengthening its Market-Leading AI-Driven Genomic and Clinical Data Platform

Jan 18, 2022

OPKO Health to Participate in the 40th Annual J.P. Morgan Healthcare Conference

Jan 5, 2022

OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 Outpatients

Dec 23, 2021

OPKO Health Receives U.S. FDA Approval for the 4Kscore® Test

Dec 8, 2021

OPKO Health Announces the Passing of Director Dr. Richard Lerner

Dec 6, 2021

BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.

Nov 29, 2021

OPKO Health Announces Participation in Piper Sandler 33rd Annual Virtual Healthcare Conference

Nov 29, 2021

OPKO Health Reports 2021 Third Quarter Business Highlights and Financial Results

Oct 28, 2021

OPKO Health to Report Third Quarter 2021 Financial Results on October 28, 2021

Oct 25, 2021

Pfizer and OPKO Announce Extension of U.S. FDA Review of Biologics License Application of Somatrogon for Pediatric Growth Hormone Deficiency

Sep 24, 2021
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...47
    Next
    © 2022 OPKO Health, Inc. All Rights Reserved.
    Privacy Policy Governance Terms of Use Sitemap